The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients
ConclusionsWe constructed a model to better predict PTLD compared to EBV DNA screening alone which could have clinical implications.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Stem Cell Therapy | Stem Cells | Study | Transplants